0001781174-21-000001.txt : 20210212 0001781174-21-000001.hdr.sgml : 20210212 20210212131559 ACCESSION NUMBER: 0001781174-21-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210212 DATE AS OF CHANGE: 20210212 EFFECTIVENESS DATE: 20210212 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Acrivon Therapeutics, Inc. CENTRAL INDEX KEY: 0001781174 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-389339 FILM NUMBER: 21625129 BUSINESS ADDRESS: STREET 1: LAB CENTRAL STREET 2: 700 NORTH MAIN STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-888-0830 MAIL ADDRESS: STREET 1: LAB CENTRAL STREET 2: 700 NORTH MAIN STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 D 1 primary_doc.xml X0708 D LIVE 0001781174 Acrivon Therapeutics, Inc. 700 N. Main Street Cambridge MA MASSACHUSETTS 02139 617-207-8979 DELAWARE None None Corporation true 2018 Peter Blume-Jensen 700 N. Main Street Cambridge MA MASSACHUSETTS 02139 Executive Officer Director Kristina Masson 700 N. Main Street Cambridge MA MASSACHUSETTS 02139 Executive Officer Director Marcin Czernik 700 N. Main Street Cambridge MA MASSACHUSETTS 02139 Director Sharon Shacham 700 N. Main Street Cambridge MA MASSACHUSETTS 02139 Director Eric Devroe 700 N. Main Street Cambridge MA MASSACHUSETTS 02139 Executive Officer Biotechnology Decline to Disclose 06b false 2021-01-28 false true false 0 15500000 15500000 0 false 2 0 0 0 false Acrivon Therapeutics, Inc. /s/ Peter Blume-Jensen Peter Blume-Jensen President 2021-02-12